+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Illumina Inc (ILMN) - Product Pipeline Analysis, 2019 Update

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • GenMark Diagnostics Inc
  • Luminex Corp
  • Qiagen NV
  • MORE
Summary

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East and Africa. Illumina is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Illumina Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • GenMark Diagnostics Inc
  • Luminex Corp
  • Qiagen NV
  • MORE
Illumina Inc Company Overview
Illumina Inc Company Snapshot
Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
Illumina Inc – Pipeline Analysis Overview
Business Description
Illumina Inc - Key Facts
Illumina Inc - Major Products and Services
Illumina Inc Pipeline Products by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc Pipeline Products Overview
Companion Diagnostic Test - Oncology
Companion Diagnostic Test - Oncology Product Overview
InfiniumDx CytoSNP-12 Assay
InfiniumDx CytoSNP-12 Assay Product Overview
Integrated MiniSeq System
Integrated MiniSeq System Product Overview
Lab-On-A-Chip
Lab-On-A-Chip Product Overview
LSD-100 Lysosomal Storage Enzyme Analyzer
LSD-100 Lysosomal Storage Enzyme Analyzer Product Overview
MRSA Screening Test
MRSA Screening Test Product Overview
NGS Diagnostic System
NGS Diagnostic System Product Overview
NGS-Based Transplant Diagnostic Assay
NGS-Based Transplant Diagnostic Assay Product Overview
Point-Of-Care Diagnostic Device- HIV
Point-Of-Care Diagnostic Device- HIV Product Overview
Portable Benchtop Analyzer - Viral Load Assay
Portable Benchtop Analyzer - Viral Load Assay Product Overview
TruSight Oncology Comprehensive
TruSight Oncology Comprehensive Product Overview
TruSight Tumor 170 CDx - LOXO-101
TruSight Tumor 170 CDx - LOXO-101 Product Overview
TruSight Tumor 170 CDx - LOXO-292
TruSight Tumor 170 CDx - LOXO-292 Product Overview
Verifi Prenatal Test
Verifi Prenatal Test Product Overview
Verifi Prenatal Test Clinical Trial
VeriSeq NIPT Solution v2
VeriSeq NIPT Solution v2 Product Overview
Illumina Inc - Key Competitors
Illumina Inc - Key Employees
Illumina Inc - Key Employee Biographies
Illumina Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

Recent Developments
Illumina Inc, Recent Developments
Jun 04, 2019: Illumina introduces expanded version of IPT Solution, offering more comprehensive detection of rare chromosomal conditions
May 29, 2019: MGI sues Illumina for patent infringement in the United States
May 03, 2019: Pacific Biosciences of California announces first quarter 2019 financial results
May 02, 2019: FBI approves Verogen’s next-gen forensic DNA technology for National DNA Index System (NDIS)
May 01, 2019: AH diagnostics is PacBio distributor
Apr 25, 2019: Illumina reports financial results for first quarter of fiscal year 2019
Apr 24, 2019: Pacific Biosciences launches new Sequel II System, featuring ~8 times the DNA sequencing data output
Apr 10, 2019: TATAA Biocenter expands its next-generation sequencing offerings with LOOP Genomics technology for long-read Illumina sequencing
Apr 08, 2019: Q2 Solutions - EA Genomics launches Illumina’s TruSight Oncology 500 Tumor Profiling assay services for the analysis of Tumor Mutational Burden
Apr 02, 2019: In study, SMRT Sequencing provides higher-resolution HLA Typing associated with improved patient survival rates

Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
Illumina Inc Pipeline Products by Equipment Type
Illumina Inc Pipeline Products by Indication
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc, Key Facts
Illumina Inc, Major Products and Services
Illumina Inc Number of Pipeline Products by Development Stage
Illumina Inc Pipeline Products Summary by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc Ongoing Clinical Trials Summary
Companion Diagnostic Test - Oncology - Product Status
Companion Diagnostic Test - Oncology - Product Description
InfiniumDx CytoSNP-12 Assay - Product Status
InfiniumDx CytoSNP-12 Assay - Product Description
Integrated MiniSeq System - Product Status
Integrated MiniSeq System - Product Description
Lab-On-A-Chip - Product Status
Lab-On-A-Chip - Product Description
LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status
LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description
MRSA Screening Test - Product Status
MRSA Screening Test - Product Description
NGS Diagnostic System - Product Status
NGS Diagnostic System - Product Description
NGS-Based Transplant Diagnostic Assay - Product Status
NGS-Based Transplant Diagnostic Assay - Product Description
Point-Of-Care Diagnostic Device- HIV - Product Status
Point-Of-Care Diagnostic Device- HIV - Product Description
Portable Benchtop Analyzer - Viral Load Assay - Product Status
Portable Benchtop Analyzer - Viral Load Assay - Product Description
TruSight Oncology Comprehensive - Product Status
TruSight Oncology Comprehensive - Product Description
TruSight Tumor 170 CDx - LOXO-101 - Product Status
TruSight Tumor 170 CDx - LOXO-101 - Product Description
TruSight Tumor 170 CDx - LOXO-292 - Product Status
TruSight Tumor 170 CDx - LOXO-292 - Product Description
Verifi Prenatal Test - Product Status
Verifi Prenatal Test - Product Description
Verifi Prenatal Test - Prospective Collection of Whole Blood Specimens From Pregnant Women at Any Risk of Fetal Chromosomal Anomaly for the Development of a Noninvasive Prenatal Test
Verifi Prenatal Test - Prospective, Multi-center, Randomized Controlled Trial Comparing Pregnancy Outcomes Following Selection and Single Embryo Transfer (SET) Based on Preimplantation Genetic Screening (PGS) by Next Generation Sequencing (NGS) Versus Standard Morphological Assessment
VeriSeq NIPT Solution v2 - Product Status
VeriSeq NIPT Solution v2 - Product Description
Illumina Inc, Key Employees
Illumina Inc, Key Employee Biographies
Illumina Inc, Other Locations
Illumina Inc, Subsidiaries
Illumina Inc, Joint Venture
Glossary

List of Figures
Illumina Inc Pipeline Products by Equipment Type
Illumina Inc Pipeline Products by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GenMark Diagnostics Inc
  • Qiagen NV
  • Affymetrix, Inc.
  • Luminex Corp
  • Oxford Nanopore Technologies Ltd
  • Thermo Fisher Scientific Inc
  • Roche Diagnostics International Ltd
  • Agilent Technologies Inc
Note: Product cover images may vary from those shown
Adroll
adroll